A previous study showed that the phosphoinositide 3-kinase/Akt/mTOR pathway is frequently overactivated in more than 80% of individuals with HNSCC (Iglesias-Bartolome et al., 2013). Here, MTOR is linked to head and neck squamous cell carcinoma.